Advair HFA Related Published Studies
Well-designed clinical trials related to Advair HFA (Fluticasone / Salmeterol)
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. [2008.06.01]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. [2007.04]
Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. [2007.04]
Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978]. [2006.02.06]
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. [2005.01]
[Efficacy and acceptability of the fixed fluticasone + salmeterol combination in the treatment of acute asthma attacks. Results of a one-year comparative study] [2004.09]
[A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination] [2003.11]
Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma. [2003.07]
Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone. [2002.06]
Well-designed clinical trials possibly related to Advair HFA (Fluticasone / Salmeterol)
Budesomide/ formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation. [2008.06]
Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. [2007.10]
Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. [2007.08]
Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. [2006.04]
Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils. [2005.11]
The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment. [2004.11]
Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. [2003.05.01]
Other research related to Advair HFA (Fluticasone / Salmeterol)
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. [2008.07.16]
The Effects of Fluticasone With or Without Salmeterol On Systemic Biomarkers of Inflammation in COPD. [2008.03.06]
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. [2007.10]
Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. [2007.06]
Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent. [2007.06]
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction. [2006.10]
Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare. [2005.03]
Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma. [2003.07]
Other possibly related research studies
Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler. [2002.01]
Pharmacological strategies for self-management of asthma exacerbations. [2006.07]
Patient-centred outcomes in primary care management of COPD - what do recent clinical trial data tell us? [2004.12]
Adherence to asthma controller medication regimens. [2005.10]
New treatment options in COPD. [2005.07]
Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study. [2005.06]
Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland. [2005.03]
Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. [2004]
Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. [2003]
Inhaled steroids in asthma. Should the doses be reduced? [2002.08]
A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance. [2007]
Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. [2007.10.17]
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. [2007.10.17]
Fixed combination therapies in COPD--effect on quality of life. [2007]
A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease. [2008.08]
Cost-Effectiveness of Therapy with Combinations of Long-Acting Bronchodilators and Inhaled Steroids for Treatment of COPD. [2008.07.11]
Inhalational diesel exhaust exposure in submariners: observational study. [2008.07]
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. [2008.07]
|
